DNTH - Dianthus Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DNTH is currently covered by 3 analysts with an average price target of $57.87. This is a potential upside of $15.74 (37.36%) from yesterday's end of day stock price of $42.13.

Dianthus Therapeutics's activity chart (see below) currently has 24 price targets and 22 ratings on display. The stock rating distribution of DNTH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.17% with an average time for these price targets to be met of 208.6 days.

Highest price target for DNTH is $63, Lowest price target is $46, average price target is $52.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 10-Nov-2025. First documented stock forecast 28-Sep-2023.

Best performing analysts who are covering DNTH - Dianthus Therapeutics:

Swayampakula Ramakanth Laura Chico Maury Raycroft Steven Seedhouse Leland Gershell

Currently out of the existing stock ratings of DNTH, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$47

$3.02 (6.87%)

$40

1 months 3 days ago
(10-Nov-2025)

5/6 (83.33%)

$10.39 (28.38%)

371

Buy

$46

$2.02 (4.59%)

$44

1 months 7 days ago
(06-Nov-2025)

7/8 (87.5%)

$9.57 (26.27%)

241

Buy

$63

$19.02 (43.25%)

$56

3 months 4 days ago
(09-Sep-2025)

1/4 (25%)

$27.43 (77.12%)

132

Buy

$52

$8.02 (18.24%)

$48

1 years 1 months 2 days ago
(11-Nov-2024)

0/2 (0%)

$24.25 (87.39%)

Buy

$39

$-4.98 (-11.32%)

$22

1 years 8 months 21 days ago
(22-Mar-2024)

2/2 (100%)

$7.06 (22.10%)

299

Show more analysts

Please expand the browser size to see the chart

What is DNTH (Dianthus Therapeutics) average time for price targets to be met?

On average it took 208.6 days on average for the stock forecasts to be realized with a an average price target met ratio 59.17

Which analyst has the current highest performing score on DNTH (Dianthus Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on DNTH (Dianthus Therapeutics) with a proven track record?

LELAND GERSHELL

Which analyst has the most public recommendations on DNTH (Dianthus Therapeutics)?

Swayampakula Ramakanth has 0 price targets and 0 ratings on DNTH

Which analyst is the currently most bullish on DNTH (Dianthus Therapeutics)?

Steven Seedhouse with highest potential upside - $19.02

Which analyst is the currently most reserved on DNTH (Dianthus Therapeutics)?

Maury Raycroft with lowest potential downside - -$4.98

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?